Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
8.55
+0.21 (2.52%)
At close: Sep 26, 2025, 4:00 PM EDT
8.53
-0.02 (-0.23%)
After-hours: Sep 26, 2025, 7:59 PM EDT
Novavax Employees
Novavax had 952 employees as of December 31, 2024. The number of employees decreased by 591 or -38.30% compared to the previous year.
Employees
952
Change (1Y)
-591
Growth (1Y)
-38.30%
Revenue / Employee
$1,133,107
Profits / Employee
$444,143
Market Cap
1.39B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
NVAX News
- 23 days ago - Novavax, Inc. (NVAX) Presents At Cantor Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 23 days ago - Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment - PRNewsWire
- 24 days ago - Novavax to Participate in the Cantor Global Healthcare Conference - PRNewsWire
- 4 weeks ago - Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S. - PRNewsWire
- 5 weeks ago - Novavax Announces Convertible Debt Refinancing - PRNewsWire
- 7 weeks ago - Novavax, Inc. (NVAX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Novavax beats quarterly revenue estimates on milestone payment - Reuters
- 7 weeks ago - Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights - PRNewsWire